evinacumab
Sign in to saveAlso known as Evkeeza
Evinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH).
~3 min read
Article
5 sectionsContents
- History
- Society and culture
- Legal status
- References
- Further reading
Evinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH).
Common side effects include nasopharyngitis (cold), influenza-like illness, dizziness, rhinorrhea (runny nose), and nausea. Serious hypersensitivity (allergic) reactions have occurred in the Evkeeza clinical trials.
Connections
human
Entity
liver
Entity
bone
Entity
medication
Entity
circulatory system
Entity
blood vessel
Entity
public domain
Entity
digital object identifier
Entity
chemical formula
Entity
insulin
Entity
neurology
Entity
testosterone
Entity
molar mass
Entity
Q180686
Entity
antigen
Entity
dietary fiber
Entity
CAS Registry Number
Entity
erythropoietin
Gene
Q229883
Entity
United States Food and Drug Administration
Entity